
Waltham-based FMS ENA Home offers quality dialysis for improved health and life.
Fresenius Medical Care North America, based in Waltham, Massachusetts, was founded with the mission to provide high-quality dialysis care and support for individuals with chronic kidney disease. The organization offers a comprehensive range of services including dialysis care, patient education, and support programs. Additionally, they manufacture dialysis products and equipment, focusing on improving patient health and quality of life. Their market focus is primarily on patients with chronic kidney conditions in North America.
Notable figures affiliated with Fresenius Medical Care North America include healthcare professionals like Dr. Benjamin Hippen, who contributes to policy discussions on organ transplant access. The company has achieved significant milestones such as opening the first patient training center for home hemodialysis in Windward O‘ahu. Their impact is evident in the enhanced quality of life for patients and the advancement of dialysis care through innovation and education.
Fresenius Medical Care Cedar Hill

Fresenius Medical Care
fresenius.com
Metropolis Dialysis Services

DaVita
davita.com

Fresenius Vascular Care
FMS Midwest Dialysis Centers

Nephrology Care Group

Liberty Dialysis

Pure Life Renal
plrenal.com

Usrc Roanoke
usrenalcare.com
Usrc Napa

Outset Medical
outsetmedical.com

Center for Dialysis Innovation

Brookhaven Medical

Balboa United
balboacare.com
Companies similar to Fresenius Medical Care North America include Fresenius Medical Care Cedar Hill, Fresenius Medical Care, Metropolis Dialysis Services and DaVita.
Fresenius Medical Care North America was founded in 1996.
Fresenius Medical Care North America's headquarters is located in Waltham, MA, US.
Fresenius Medical Care North America's most recent funding round was for $16.4M (USD) in January 2024.
As of Jan 15, 2024, Fresenius Medical Care North America has raised a total of $99.7M (USD).
Fresenius Medical Care North America has 30 employees as of Feb 5, 2024.